![]() |
產(chǎn)地 | 進(jìn)口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS10665 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-PP-1B |
克隆性 | |
靶點(diǎn) | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標(biāo)識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human PP-1B C-terminus |
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. 蛋白磷酸酯酶-1B抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件;
3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細(xì)胞可導(dǎo)致高本底。
產(chǎn)品訂購信息:
英文名稱 Anti-PP-1B
中文名稱 蛋白磷酸酯酶-1B抗體費(fèi)用
別 名 Protein phosphates-1; PP-1 gamma, beta, alpha, catalytic subunit; MGC3672; PP 1B; PP-1B; PPP1CB; PP1B; PPP1CD; PP1beta; Protein phosphatase 1 beta; Protein phosphatase 1 catalytic subunit beta isoform; Protein phosphatase 1 delta; Serine threonine protein phosphatase PP1 beta catalytic subunit; Serine/threonine-protein phosphatase PP1-beta catalytic subunit; PP1B_HUMAN; Protein phosphatase 1, catalytic subunit, beta isozyme; Protein phosphatase 1, catalytic subunit, delta isoform;
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Mouse
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Cow, Horse, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 神經(jīng)生物學(xué) 信號轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 37kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PP-1B C-terminus
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
蛋白磷酸酯酶-1B抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The phosphorylation and de phosphorylation of proteins on serine and threonine residues is an essential means of regulating a broad range of cellular functions in eukaryotes, including division, homeostasis and apoptosis. A geoup of proteins that are intimately involved in this process are the serine/ threonine protein phosphatases. The protein phosphatases (PP) holoenzyme is a trimertic complex composed of a regulatory subunit, a variable subunit and a catalytic subunit. Four major families of protein phosphatase catalytic subunits have been identified and are designated PP1, PP2A, PP2B (calcineurin) and PP2C. An additional protein phosphatase catalytic subunit, PPX or PP4, is the member of a potentially novel PP family. The PP1 family is composed of subfamily members PP1 alpha, PP1 beta,and PP1 gamma.The PP2A family iscomposed of subfamily members PP2A alpha,and PP2A beta. The PP2B family is composed of subfamily members PP2B-A alpha, PP2B-A beta and PP2B-A gamma. The PP2C family is composed of PP2C alpha, PP2C beta, PP2C gamma. Wip1, a protein isentified in the p53 DNA response pathway, has also been identified as a potential member of the PP2C family. Regulatary subunits include dnuclear inhibitor of PP1(NIPP1), PP2A-AAlphaand–A beta, PP2A-B alpha and B beta,PP2A-C alpha and C beta, PP2A-B56-alpha and–B56 beta, PR48 and PP2B-B1 and–B2.
Function : Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase (PP1) is essential for cell division, it participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase.
Subunit : PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or PPP1CC, which is folded into its native form by inhibitor 2 and glycogen synthetase kinase 3, and then complexed to one or several targeting or regulatory subunits. The targeting or regulatory subunits determine the substrate specificity of PP1. PPP1R12A, PPP1R12B and PPP1R12C mediate binding to myosin. PPP1R3A (in skeletal muscle), PPP1R3B (in liver), PPP1R3C, PPP1R3D and PPP1R3F (in brain) mediate binding to glycogen. Part of a complex containing PPP1R15B, PP1 and NCK1/2 (By similarity). Component of the MLL5-L complex, at least composed of MLL5, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT. Interacts with PPP1R7 and PPP1R12C. PPP1R15A and PPP1R15B mediate binding to EIF2S1. Interacts with PPP1R16B. Component of the PTW/PP1 phosphatase complex, composed of PPP1R10/PNUTS, TOX4, WDR82, and PPP1CA or PPP1CB or PPP1CC. Interacts with PPP1R8. Interacts with TRIM28; the interaction is weak. Interacts with PPP1R12A and NUAK1; the interaction is direct.
Subcellular Location : Cytoplasm. Nucleus. Nucleus, nucleoplasm. Nucleus, nucleolus. Note=Highly mobile in cells and can be relocalized through interaction with targeting subunits. In the presence of PPP1R8 relocalizes from the nucleus to nuclear speckles.
Database links : UniProtKB/Swiss-Prot: P62140.3
抗體的鑒定:
1)蛋白磷酸酯酶-1B抗體費(fèi)用 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識別能力??贵w的特異性高,它的識別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競爭抑制試驗(yàn)測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測定對抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
Anti-CD20/Biotin 生物素化CD20抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-HOXc8/FITC 熒光素標(biāo)記同源盒基因的一種抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh CDC27/ANAPC3 后期促進(jìn)復(fù)合蛋白3抗體 規(guī)格 0.1ml
Adipo R1(adiponectin receptor 1) 脂聯(lián)素受體-1(抗原) 0.5mg
IBP160 英文名稱: 160kDa內(nèi)含子結(jié)合蛋白抗體 0.2ml
Rhesus antibody Rh TDRD9/HIG1 缺氧誘導(dǎo)蛋白HIG1抗體 規(guī)格 0.2ml
Anti-HOXc8/FITC 熒光素標(biāo)記同源盒基因的一種抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-KCNA5/FITC 熒光素標(biāo)記通道混合相關(guān)蛋白亞型5抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-phospho-Smad2(p-Ser465) /FITC 熒光素標(biāo)記兔抗人、大、小鼠、,馬,犬,雞磷酸化Smad2抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh ALDH2/ALDHI 乙醛脫氫酶2抗體 規(guī)格 0.2ml
Rabbit Anti-human IgG/Alexa Fluor 488 Alexa Fluor 488標(biāo)記的兔抗人IgG 0.1ml
GLYATL1 英文名稱: 甘胺酸-N-?;D(zhuǎn)移酶樣1抗體 0.2ml
Rhesus antibody Rh Rabbit Anti-Guinea pig IgG/HRP 辣根過氧化物酶標(biāo)記的兔抗豚鼠IgG 規(guī)格 0.1ml
Anti-phospho-Smad2(p-Ser465) /FITC 熒光素標(biāo)記兔抗人、大、小鼠、,馬,犬,雞磷酸化Smad2抗體IgGMulti-class antibodies規(guī)格: 0.2ml
CG(Human Cryoglobulin) ELISA Kit 人冷球蛋白Multi-class antibodies規(guī)格: 48T
Anti-PTP-1B 蛋白酪氨酸磷酸酶-1BMulti-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh HAVCR1/TIM1 腎損傷分子1抗體(病毒細(xì)胞受體1) 規(guī)格 0.1ml
IDUA(Mouse Alpha-L-iduronidase) ELISA Kit 小鼠αL艾杜糖苷酸酶 96T
Phospho-p63 (Ser160+Ser162) 英文名稱: 磷酸化P63抑制基因抗體 0.1ml
phospho-BAD (Ser75) 英文名稱: 磷酸化相關(guān)死亡促進(jìn)因子抗體 0.1ml
Anti-PTP-1B 蛋白酪氨酸磷酸酶-1BMulti-class antibodies規(guī)格: 0.1ml
CL-0194RF/6A(猴視網(wǎng)膜內(nèi)皮細(xì)胞)5×106cells/瓶×2
TCN2 Others Human 人 TCN2 / anscobalamin-II CHO細(xì)胞裂解液 (陽性對照)
人脈絡(luò)叢上皮細(xì)胞cDNAHCPEpiC cDNA
豬小腸上皮細(xì)胞;ZYM-DIEC02 成細(xì)胞,Saos-2細(xì)胞 RuCa細(xì)胞,小鼠細(xì)胞株
人胚腎細(xì)胞-F克隆;293F
HA Others H5N1 甲型 H5N1 (A/goose/Guiyang/337/2006) 血凝素HA1 (Hemagglutinin) 人細(xì)胞裂解液 (陽性對照)
CL-0192RBL-2H3(大鼠嗜堿性細(xì)胞細(xì)胞)5×106cells/瓶×2
AGO2 Others Human 人 AGO2 / Argonaute 2 / EIF2C2 桿狀病毒-昆蟲細(xì)胞裂解液 (陽性對照)
人周細(xì)胞cDNAHBVP cDNA
B16細(xì)胞,小鼠細(xì)胞 人小細(xì)胞細(xì)胞,LTEP-sm細(xì)胞 角膜內(nèi)皮細(xì)胞Many types of cells包裝:5 × 105次方(1ml)
犬腎細(xì)胞系/IgR;MDCK/IgR
PLAT Others Human 人 PLAT / tPA 人細(xì)胞裂解液 (陽性對照)
蛋白磷酸酯酶-1B抗體費(fèi)用 CD5 Others Rat 大鼠 CD5 人細(xì)胞裂解液 (陽性對照)
人結(jié)細(xì)胞;T84
人胎盤羊膜細(xì)胞完全培養(yǎng)基 100mL
SAC-II B2細(xì)胞,小鼠腹水瘤細(xì)胞 BRL 3A(大鼠肝細(xì)胞) 人皮膚成纖維細(xì)胞;CCC-HSF-1
CCL11 Protein Human 重組人 CCL11 蛋白 (His 標(biāo)簽)
RD(人惡性胚胎橫紋肌瘤細(xì)胞) 5×106cells/瓶×2 小鼠 Angiopoietin-2 / ANG2 / ANGPT2 人細(xì)胞裂解液 (陽性對照)